Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer.
Robin L JonesThomas J HerzogShreyaskumar R PatelMargaret von MehrenScott M SchuetzeBrian Andrew Van TineRobert L ColemanRoland KnoblauchSpyros TriantosPeter HuWaleed ShalabyTracy McGowanBradley J MonkGeorge D DemetriPublished in: Cancer medicine (2021)
For patients with STS or ROC who still have limited treatment options, trabectedin may be initiated after carefully considering benefit versus risk. Trial Registration (ClinicalTrials.gov): NCT01343277; NCT00113607; NCT01846611.